Clinical trial
ACCELerated Inhibition of Platelet Aggregation, Inflammation and Ischemia-reperfusion Injury by Adjunctive Cilostazol Loading in Patients With Acute Coronary Syndrome
NCT01354808 is registered in ClinicalTrials.gov with Gyeongsang National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ACCELerated Inhibition of Platelet Aggregation, Inflammation and Ischemia-reperfusion Injury by Adjunctive Cilostazol Loading in Patients With Acute Coronary Syndrome
- Lead sponsor
- Gyeongsang National University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- Not reported
- Enrollment
- 220 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anti-inflammatory agent, myocardial reperfusion injury, platelet aggregation inhibitors